← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Amelia Technologies, Llc
Washington, DC
$7,698,439
Total funding
8
Grants
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,698,439 · 8
By mechanism
R44$3,700,164 · 3
R42$3,174,204 · 2
R43$577,489 · 2
R41$246,582 · 1
Investigators at Amelia Technologies, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of the UValidate platform for the profiling of topically applied chemical agents.$863,724
R42 · FY2023 · ES
Novel genotoxicity assay incorporating the toxicogenomics biomarker TGx-28.65 with a direct digital counting$840,491
R44 · FY2018 · ES
Barcoded human cells engineered with heterozygous genetic diversity to uncover toxicodynamic variability$840,048
R44 · FY2022 · ES
Barcoded human cells engineered with heterozygous genetic diversity to uncover toxicodynamic variability$839,705
R44 · FY2023 · ES
Immuno-CometChip for Human Skin Basal Cell Genotoxicity Testing$826,926
R42 · FY2019 · ES
Development of the UValidate platform for the profiling of topically applied chemical agents.$809,224
R42 · FY2022 · ES
Immuno-CometChip for Human Skin Basal Cell Genotoxicity Testing$666,400
R42 · FY2018 · ES
Novel genotoxicity assay incorporating the toxicogenomics biomarker TGx-28.65 with a direct digital counting$655,411
R44 · FY2019 · ES
Using microsphere technology for the electrochemical measurement of genotoxicity.$303,165
R43 · FY2025 · ES
EcoWell- A planet in a plate.$274,458
R44 · FY2024 · ES
The development of FastMyco⢠: A novel isothermal colorimetric assay for the rapid detection of mycoplasma contamination .$274,324
R43 · FY2020 · GM
Barcoded human cells engineered with heterozygous genetic diversity to uncover toxicodynamic variability$250,051
R44 · FY2021 · ES
Optimization of the UValidate platform to measure genotoxicity associated with current problematic UV chemical blockers$195,416
R41 · FY2020 · ES
Optimization of the UValidate platform to measure genotoxicity associated with current problematic UV chemical blockers$51,166
R41 · FY2021 · ES
Expansion of Immuno-CometChip Platform$7,930
R42 · FY2019 · ES